What does “Hepatitis C antibody test” mean?

Anti-HCV antibody testing is a blood test used to determine whether an individual has been infected with the hepatitis C virus (HCV). The analysis is as follows:

Anti-HCV antibodies are markers of the body’s immune response to HCV infection. Upon exposure to HCV, the immune system produces specific antibodies to combat the virus. Anti-HCV antibody testing detects the presence of these antibodies in the blood, thereby indicating whether an individual has been previously or is currently infected with HCV.

Anti-HCV antibody testing is typically performed via blood sampling. A healthcare provider draws a blood sample from the patient, which is then sent to a laboratory for analysis. Commonly used detection methods include chemiluminescence immunoassay (CLIA), colloidal gold immunochromatography, and Western blot assay. These methods offer high sensitivity and specificity, enabling accurate detection of anti-HCV antibodies in blood.

A positive anti-HCV antibody test result suggests that the patient may have been previously or is currently infected with hepatitis C virus. A negative result generally indicates that no anti-HCV antibodies were detected at the time of testing; however, this does not definitively rule out current hepatitis C virus infection—particularly during the early “window period” before seroconversion. If there is any uncertainty or concern regarding the anti-HCV antibody test result, patients should promptly consult their physician for further evaluation and appropriate management.